-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Pharmacological intervention
-
Plitidepsin
-
Antineoplastic agent
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Fragile population
-
Immunocompromised host
-
Hospital
-
SARS-CoV-2
-
Pharmacological intervention
-
Antivirals
-
Plitidepsin
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Pharmacological intervention
-
Antivirals
-
Plitidepsin